Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lamotrigine--an update

M J Brodie1

  • 1University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perampanel for focal epilepsy: insights from early clinical experience.

Acta neurologica Scandinavica·2015
Same author

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

Acta neurologica Scandinavica. Supplementum·2012
Same author

Patterns of treatment response in newly diagnosed epilepsy.

Neurology·2012
Same author

Adjunctive pregabalin for uncontrolled partial-onset seizures: findings from a prospective audit.

Acta neurologica Scandinavica·2011
Same author

Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions.

Biochemical pharmacology·2010
Same author

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.

Neurology·2010
Same journal

Ictal Asystole or Vasovagal Syncope? A Diagnostic Pitfall in Pediatric Drug-Resistant Epilepsy.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same journal

Validation of an ICD-10 Code for Diplopia in the Emergency Department: A Retrospective Cohort Study.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same journal

Practice Patterns and Care Gaps in Lennox Gastaut Syndrome: A call for Action.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same journal

Isolated Achiasma Discovered at Age 86: A Rare Cause of see-saw nystagmus and bitemporal hemianopia.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same journal

Post-Stroke Parakinesia Brachialis Oscitans: Clinical Insights from a Case Series.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same journal

A Neuronal Perspective.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
See all related articles

Lamotrigine (LTG) is an effective antiepileptic drug for various seizure types, demonstrating similar efficacy to older agents but with better tolerability. It works by prolonging sodium channel slow inactivation, reducing excitatory amino acid release.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Clinical Neurology

Background:

  • Epilepsy is a neurological disorder characterized by recurrent seizures.
  • Refractory epilepsy often requires novel therapeutic agents.
  • Lamotrigine (LTG) is an antiepileptic drug (AED) with a unique mechanism of action.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of lamotrigine (LTG) in various epilepsy types.
  • To compare LTG with established AEDs like carbamazepine and phenytoin.
  • To detail LTG's pharmacokinetic and pharmacodynamic interactions.

Main Methods:

  • Review of 11 pivotal double-blind add-on trials in refractory partial seizures.
  • Anecdotal data analysis for other seizure types (absences, myoclonic, tonic-clonic, Lennox-Gastaut syndrome, infantile spasms).

Related Experiment Videos

  • Double-blind trials comparing LTG with carbamazepine and phenytoin in newly diagnosed epilepsy.

    • Main Results:

    • LTG demonstrated efficacy in refractory partial seizures and showed comparable efficacy to carbamazepine and phenytoin in newly diagnosed epilepsy.
    • LTG was better tolerated than carbamazepine and phenytoin, with common side effects including headache, nausea, and dizziness.
    • Rash occurred in <5% of patients; incidence reduced by slow titration and avoiding concomitant sodium valproate.
    • LTG has a long elimination half-life and does not affect hepatic metabolic processes, but interactions with enzyme inducers and carbamazepine require dose adjustments.

    Conclusions:

    • Lamotrigine is a well-tolerated AED with broad-spectrum efficacy for various seizure types.
    • Its favorable tolerability profile makes it a valuable option, especially compared to older AEDs.
    • Understanding LTG's interactions is crucial for optimizing patient treatment and minimizing adverse effects.